Select regions whose content you would like to see
Supplementary protection certificates (SPCs) are not available for formulations of medicines that contain substances previously authorised for use in the EU, the EU's highest court has ruled. 22 Mar 2019
The UK's impending exit from the EU was a leading factor in a High Court judge's recent decision to seek immediate clarity from the EU's highest court on how to interpret EU intellectual property (IP) laws concerning supplementary protection certificates (SPCs).... 05 Mar 2019
Businesses found to have infringed patent rights can face potentially substantial bills for compensation and a block on the manufacture, supply and sale of infringing products.
Businesses that are involved in patent litigation incur costs when engaging legal advisers. Some of these costs may be recoverable from the other side, but there are rules around costs that parties to litigation should familiarise themselves with.
Patent rights are property rights and as such can be assigned, mortgaged, licensed, etc… However, when assigning a patent there are strict requirements and procedures that the patentee must adhere to and follow.
Bringing or defending a patent claim before the courts can be a daunting prospect, not least because of the complicated nature of patents and patent law. It is vital that businesses understand the procedures that govern how patent trials operate.
When patents are granted they provide inventors up to 20 years of protection for their invention, but there are circumstances in which patents can be revoked.
Businesses can face claims of patent infringement if they carry out acts infringing patented products or processes without the consent of patent rights holders. However, UK patent law contains a number of defences against infringement which businesses may...
EU law makers have agreed to update intellectual property (IP) laws to allow European manufacturers of generic and biosimilar medicines to better compete in global markets, but a body representing some of Ireland's biggest pharmaceutical companies has said... 21 Feb 2019
ANALYSIS: A push to set new principles around the licensing of standard-essential patents highlights the growing number of businesses whose operations, products and services now rely on standardised technology. 04 Feb 2019
We see patents as a business tool. Our dedicated team of patent specialists advise clients from a range of industries on how to: secure market exclusivity for their inventions; access new markets through licensing technologies or challenging blocking patents; and, maximise the value of their innovation through strategic patent portfolio management and exploitation.
More about Patents
Partner - Head of IP & Life Sciences